Novo Nordisk enters talks to buy device maker Biocorp

Novo Nordisk announced Monday morning that it has entered into exclusive negotiations to buy French device maker Biocorp.

The Danish pharma giant is seeking to acquire a controlling stake in the company from majority shareholder Bio Jag for around $165 million. This represents a nearly 20% premium on Biocorp’s closing marketing price on June 2.